I.R.N. Verly - Concepedia

Author

I.R.N. Verly

Princess Máxima Center ORCID

Also Known As

I.R.N. Verly, Iedan R. N. Verly, Iedan R. N. Verly, Iedan R.N. Verly, Iedan RN Verly, Iedan Verly

Publications

227

Citations

H-Index

Concepts

All Affiliations

Princess Máxima Center Emma Kinderziekenhuis Amsterdam University Medical Centers Amsterdam UMC Location Vrije Universiteit Amsterdam Leiden University

About

I.R.N. Verly is an author at Princess Máxima Center specializing in medicine, neuro-oncology, and neuroblasts.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	140
2	Neuro-oncology	3	3	118
3	Neurology	2	2	95
4	Neuroscience	2	2	97
5	Clinical Chemistry	1	1	21

I.R.N. Verly

Publications

223

Citations

H-Index

Page 1

	Year	Citations
Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients I.R.N. Verly, André B. P. Kuilenburg, N. G. G. M. Abeling, European Journal of Cancer Neuro-oncologyNeuroblastoma PatientsNeuroblastsNeuroscienceNeurology	2017	73
mi<scp>R</scp> expression profiling at diagnosis predicts relapse in pediatric precursor <scp>B</scp>‐cell acute lymphoblastic leukemia Smadar Avigad, I.R.N. Verly, Asaf Lebel, Genes Chromosomes and Cancer	2015	44
Catecholamine excretion profiles identify clinical subgroups of neuroblastoma patients I.R.N. Verly, René Leen, J.R. Meinsma, European Journal of Cancer Neuro-oncologyCatecholamine Excretion ProfilesNeuroendocrine DisorderNeuroblastsNeuroscience	2019	24
Hypermethylated <i>RASSF1A</i> as Circulating Tumor DNA Marker for Disease Monitoring in Neuroblastoma Lieke M. J. van Zogchel, Esther M. van Wezel, Jalenka van Wijk, JCO Precision Oncology	2020	23
3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients I.R.N. Verly, André B. P. Kuilenburg, N. G. G. M. Abeling, European Journal of Cancer Neuroblastoma PatientsMedicinePoor Clinical OutcomeNeurologyHigh-grade Gliomas	2017	22
Plasma free metanephrines for diagnosis of neuroblastoma patients Sebastiano Barco, I.R.N. Verly, Maria Valeria Corrias, Clinical Biochemistry Neuro-oncologyTumor InnervationPlasma Free MetanephrinesGliomaMedicine	2019	21
Optimising urinary catecholamine metabolite diagnostics for neuroblastoma Yvette A.H. Matser, I.R.N. Verly, Maria van der Ham, Pediatric Blood & Cancer	2023	16

Page 1